Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Multiple congenital malformations associated with topical tretinoin.

Navarre-Belhassen C, Blanchet P, Hillaire-Buys D, Sarda P, Blayac JP.

Ann Pharmacother. 1998 Apr;32(4):505-6. No abstract available.

PMID:
9562150
2.

Multiple congenital defects associated with maternal use of topical tretinoin.

Lipson AH, Collins F, Webster WS.

Lancet. 1993 May 22;341(8856):1352-3. No abstract available.

PMID:
8098487
3.

Birth defects due to topical adapalene and tretinoin.

[No authors listed]

Prescrire Int. 1998 Oct;7(37):148-9.

PMID:
10915421
4.

Are topical retinoids teratogenic?

Veraldi S, Rossi LC, Barbareschi M.

G Ital Dermatol Venereol. 2016 Dec;151(6):700-705. Epub 2016 Sep 6. Review.

PMID:
27598619
5.

Use of topical tretinoin and the development of noncutaneous adverse events: evidence from a systematic review of the literature.

Shapiro S, Heremans A, Mays DA, Martin AL, Hernandez-Medina M, Lanes S.

J Am Acad Dermatol. 2011 Dec;65(6):1194-201. doi: 10.1016/j.jaad.2010.10.014. Epub 2011 May 6. Review.

PMID:
21550137
6.

[Congenital malformations due to accutane].

Tremblay M, Voyer P, Aubin G.

Can Med Assoc J. 1985 Aug 1;133(3):208. French. No abstract available.

7.

Otocerebral anomalies associated with topical tretinoin use.

Selcen D, Seidman S, Nigro MA.

Brain Dev. 2000 Jun;22(4):218-20.

PMID:
10838106
8.

Schizophreniform Psychosis During Treatment With Alitretinoin.

Bumb JM, Solojenkina X, Zink M.

J Clin Psychopharmacol. 2015 Oct;35(5):612. doi: 10.1097/JCP.0000000000000377. No abstract available.

PMID:
26252440
9.

Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne.

Piérard-Franchimont C, Henry F, Fraiture AL, Fumal I, Piérard GE.

Dermatology. 1999;198(2):218-22.

PMID:
10325486
10.

Short contact therapy of acne with tretinoin.

Veraldi S, Barbareschi M, Benardon S, Schianchi R.

J Dermatolog Treat. 2013 Oct;24(5):374-6. doi: 10.3109/09546634.2012.751085. Epub 2013 Jan 20.

PMID:
23167277
11.

Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies.

Dosik JS, Gilbert RD, Arsonnaud S.

Skinmed. 2006 Sep-Oct;5(5):219-23.

PMID:
16957432
12.

First-trimester exposure to topical tretinoin: its safety is not warranted.

Martínez-Frías ML, Rodriguez-Pinilla E.

Teratology. 1999 Jul;60(1):5. No abstract available.

PMID:
10413331
13.

Tretinoin and pregnancy.

Caron GA.

Lancet. 1993 Jun 26;341(8861):1664. No abstract available.

PMID:
8100028
14.

Cumulative irritation potential of topical retinoid formulations.

Leyden JJ, Grossman R, Nighland M.

J Drugs Dermatol. 2008 Aug;7(8 Suppl):s14-8.

PMID:
18724650
15.

Absorption of tretinoin in rats and rabbits following oral and dermal application.

Chou R, Bürgin H, Schmitt G, Eggers H.

Arzneimittelforschung. 1997 Apr;47(4):401-5.

PMID:
9150861
16.

Late onset of headache in a patient treated with alitretinoin.

Gurreri R, Pistone G, LA Vecchia M, Bongiorno MR.

G Ital Dermatol Venereol. 2016 Apr;151(2):209-10. Epub 2015 Oct 9. No abstract available.

PMID:
26449913
17.

Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy.

Loureiro KD, Kao KK, Jones KL, Alvarado S, Chavez C, Dick L, Felix R, Johnson D, Chambers CD.

Am J Med Genet A. 2005 Jul 15;136(2):117-21.

PMID:
15940677
18.

Safety of first-trimester exposure to topical tretinoin: prospective cohort study.

Shapiro L, Pastuszak A, Curto G, Koren G.

Lancet. 1997 Oct 18;350(9085):1143-4. No abstract available.

PMID:
9343507
19.
20.

Topical retinoids during pregnancy (continued).

[No authors listed]

Prescrire Int. 2005 Jun;14(77):100-1.

PMID:
15981398

Supplemental Content

Support Center